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Abstract
Alveolar macrophages (AMs) can phagocytose unopsonized pathogens such as S. aureus via innate immune receptors, such
as scavenger receptors (SRs). Cytoskeletal events and signaling pathways involved in phagocytosis of unopsonized bacteria
likely govern the fate of ingested pathogens, but are poorly characterized. We have developed a high-throughput scanning
cytometry-based assay to quantify phagocytosis of S. aureus by adherent human blood-derived AM-like macrophages in a
96-well microplate format. Differential fluorescent labeling of internalized vs. bound bacteria or beads allowed automated
image analysis of collapsed confocal stack images acquired by scanning cytometry, and quantification of total particles
bound and percent of particles internalized. We compared the effects of the classic SR blocker polyinosinic acid, the
cytoskeletal inhibitors cytochalasin D and nocodazole, and the signaling inhibitors staurosporine, Go ¨ 6976, JNK Inhibitor I
and KN-93, on phagocytosis of a panel of live unopsonized S. aureus strains, (Wood, Seattle 1945 (ATCC 25923), and
RN6390), as well as a commercial killed Wood strain, heat-killed Wood strain and latex beads. Our results revealed failure of
the SR inhibitor polyinosinic acid to block binding of any live S. aureus strains, suggesting that SR-mediated uptake of a
commercial killed fluorescent bacterial particle does not accurately model interaction with viable bacteria. We also observed
heterogeneity in the effects of cytoskeletal and signaling inhibitors on internalization of different S. aureus strains. The data
suggest that uptake of unopsonized live S. aureus by human macrophages is not mediated by SRs, and that the cellular
mechanical and signaling processes that mediate S. aureus phagocytosis vary. The findings also demonstrate the potential
utility of high-throughput scanning cytometry techniques to study phagocytosis of S. aureus and other organisms in greater
detail.
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Introduction
Staphylococcus aureus is an increasingly frequent and dangerous
cause of both community and hospital-acquired pneumonia [1].
The alveolar macrophage (AM) is the primary resident defender
against inhaled pathogens such as S. aureus that reach the alveoli.
In the absence of specific opsonizing antibodies, the AMs ability to
clear these pathogens depends upon its innate immune receptors
for binding and internalization. In particular, the group of
molecular pattern recognition receptors (PRR) collectively known
as scavenger receptors (SRs) function in the uptake of unopsonized
bacterial pathogens [2–9]. SRs are a diverse group of receptors
with broad and overlapping specificities that mediate binding and
internalization of many polyanionic ligands, including bacteria
and their cell wall components, oxidized low density lipoproteins,
environmental dusts, apoptotic cells, and CpG DNA. To date,
eight classes of SA (A-H) have been described (reviewed in [10]).
The most extensively studied in terms of their potential roles in
host defense against S. aureus are the class A scavenger receptors
SR-AI/II, and macrophage receptor with collagenous structure
(MARCO). SR-A I/II binds both Gram-positive and Gram-
negative bacteria and their respective cell wall products lipotei-
choic acid and lipopolysaccaride [3,6,11]. Investigators have used
a convenient fluorescence-labeled S. aureus to observe its SR-AI/
II-mediated phagocytosis by SR-A transfected CHO cells as well
as by human bone-marrow derived macrophages [6]. Moreover,
SR-A deficient mice have diminished clearance of S. aureus and
survival following IP infection, and macrophages from SR-A
deficient mice exhibit diminished phagocytosis of S. aureus [5].
Another class A SR, MARCO, also binds E. coli and S. aureus, and
this binding is blocked by anti-MARCO antibody, as well as by the
general SR binding inhibitors polyinosinic acid and polyguanylic
acid [2,8,12]. Other SRs that have been implicated as potential
mediators of unopsonized pathogen phagocytosis by macrophages
include the class A scavenger receptor with C-type lectin (SRCL),
also known as collectin placenta-1 (CL-P1) [13–15], the class E
lectin-like oxidized low-density lipoprotein receptor (LOX-1) [16–
19], and the class G scavenger receptor that binds phosphatidyl-
serine and oxidized lipoprotein (SR-PSOX), also known as CXC
chemokine ligand 16 (CXCL16) [20,21].
The binding of pathogen ligands or opsonins by macrophage
surface receptors initiates signaling cascades. These, in turn, that
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(possibly) for cell activation responses. The signaling events and
cytoskeletal elements and activities involved in FccR-mediated and
CR-mediated phagocytosis have been fairly well characterized
[22–34]. We have previously used a scanning cytometry assay to
analyze macrophage phagocytosis of unopsonized latex beads.
This study revealed that several cytoskeletal and signaling
components previously implicated in FccR-mediated phagocytosis
(tyrosine kinases, protein kinase C (PKC), in complement-
mediated phagocytosis (microtubules), or in both (actin, phospho-
inositide 3-kinase (PI3K)), as well the MAPK family members JNK
and MEK/ERK, are important factors in macrophage uptake of
unopsonized albumin-coated latex beads [35].
To allow similar analysis of unopsonized phagocytosis of specific
bacterial pathogens we have developed high-throughput fluores-
cent scanning cytometry-based methods for quantification of
phagocytosis of S. aureus by adherent human alveolar-like
macrophages in a 96-well microplate format. Methods for
differential fluorescent labeling of internalized vs. external bacteria
were devised to enable automated image analysis of collapsed
confocal stack images from scanning cytometry. Analysis and
quantification software was developed to provide enumeration of
internalized, bound external and total bacteria per cell, and
calculation of mean bacteria per cell and fraction of bacteria
internalized within each microplate well. The format made it
possible to test a panel of inhibitors of pathways related to
phagocytosis. The data confirmed the role of scavenger receptors
in binding of the popular commercially available fluorescent S.
aureus-derived particles. In contrast, macrophages showed SR-
independent uptake of a panel of other S. aureus strains (live and
heat-killed). Strain-specific heterogeneity in the effects of signaling
inhibitors was also seen.
Materials and Methods
Human cell isolation and preparation
Human peripheral blood monocyte-derived, granulocyte and
macrophage-colony stimulating factor (GM-CSF)-matured MFs
(GM-MFs) were prepared as previously described [35]. Briefly,
buffy coats harvested from blood obtained from discarded platelet
apheresis collars obtained from the Kraft Family Blood Donor
Center at the Dana Farber Cancer Institute (Boston, MA, USA)
were enriched for monocytes using the RosetteSep Monocyte
Enrichment kit (Stem Cell Technologies, Vancouver, BC,
Canada). Monocytes were cultured in Vuelife bags (American
Fluoroseal, Gaithersburg, MD, USA) at 5% CO2 and 37uCi n
RPMI/10% FBS with 20 mg/ml gentamycin and 20 ng/ml
human recombinant GM-CSF (Peprotech, Rocky Hill, NJ,
USA). For adherent cell studies harvested cells were resuspended
at 5610
5/ml in RPMI/10% FBS and dispensed into black-walled
96 well Micro-Clear plates (Greiner Bio-One, Monroe, NC, USA)
at 1610
5 cells/well, and incubated for 48 hours at 5% CO2 and
37uC. For suspension cell flow cytometry studies harvested cells
were resuspended at 5610
5/ml in RPMI/ 0.3% BSA and stored
on ice until time of assay (less than one hour).
Mouse cell isolation and preparation
Animal experiments and husbandry were approved by the
Harvard Medical Area Standing Committee on Animals. 4–6
week-old female BALB/c mice (Jackson Laboratory, Bar Harbor,
ME, USA) were injected i.p. with 2 ml aged thioglycolate broth
(Sigma-Aldrich, St. Louis, MO, USA). Four days post injection
mice were anesthetized with isofluorane and euthanized by
cervical dislocation. Peritoneal lavage was performed with 10 ml.
ice-cold PBS and pooled samples from three mice were centrifuged
at 5006g for 8 minutes. Cells were resuspended at 5610
5/ml in
RPMI/10% FBS and dispensed into black-walled 96 well Micro-
Clear plates (Greiner Bio-One, Monroe, NC, USA) at 1610
5
cells/well, and incubated for 48 hours at 5% CO2 and 37uC.
Preparation of live S. aureus suspensions
S. aureus strains Seattle 1945 (ATCC 25923), Wood, and ATCC
12598 (Cowan 1) were purchased from American Type Culture
Collections (ATCC, Manassas, VA, USA). Green fluorescent
protein (GFP)-expressing S. aureus strain RN6390 was generously
donated by Dr. Ambrose Cheung, Dartmouth Medical School,
Hanover, NH, USA). 300 mL of thawed 280uC frozen S. aureus
stocks were added to 10 ml of Tryptic Soy broth (with 2.5 mg/ml
chloramphenicol selection agent for GFP+ RN6390) in 50 ml
conical centrifuge tubes, and incubated at 37uC while shaking at
250 rpm for four hours. Bacteria were washed twice in cold PBS
and resuspended in cold PBS, vortexed for two minutes and passed
through a 5 mm syringe filter. OD 650 was used to estimate CFU
from standard curves. For unopsonized experiments bacteria were
suspended in cold RPMI/.3%BSA without serum or phenol red
(assay buffer) at 2.67610
8/ml and kept on ice until infection of
cells. For IgG-opsonized experiments bacteria were diluted to
4610
8/ml in assay buffer, incubated on ice for 30 minutes with
5 mg/ml mouse monoclonal IgG3 anti-S. aureus antibody
(C55570M, Biodesign International, Saco, ME, USA), washed
twice in cold PBS, resuspended in assay buffer at 4610
7/ml, and
kept on ice until infection of cells.
Preparation of heat-killed S. aureus Wood strain
suspension
Live S. aureus Wood strain were prepared as described above.
Following OD 650 determination bacteria (suspended in PBS)
were incubated in a water bath heated to 63uC for 30 minutes,
cooled on ice, centrifuged and resuspended in assay buffer at
2.67610
8/ml and kept on ice until infection of cells.
Preparation of commercial killed S. aureus Wood strain
suspension
Lyopholized AlexaFluor 488-conjugated heat or irradiation
killed Wood strain S. aureus (Life Technologies, Carlsbad, CA,
USA) was suspended in cold assay buffer at a concentration of
1.33610
7/ml and sonicated for 20 seconds immediately prior to
use.
Phagocytosis assay: latex beads
All reagents and buffers were at room temperature when added
to cells, and all incubations were at 5% CO2 and 37uC. Adherent
GM-MFs prepared as described above were incubated with
100 mM CellTracker Blue CMAC (Life Technologies) in HBSS
with Ca
++ and Mg
++ for 40 minutes at 5% CO2 and 37uC,
followed by replacement with RPMI/.3%BSA without serum or
phenol red (assay buffer). Inhibitors or control solutions (table 1)
were added to cells (with triplicate wells for each condition) 40
minutes prior to addition of beads. Polyinosinic acid, chondroitin
sulfate, cytochalasin D, nocodazole, and staurosporine were
purchased from Sigma-Aldrich (St. Louis, MO, USA). Go ¨ 6976,
JNK Inhibitor I, JNK Inhibitor I control, and KN-93 were
purchased from EMD Chemicals (San Diego, CA, USA).
For latex bead uptake assays, one micron green fluorescent
carboxylated latex beads (Life Technologies) were biotinylated as
previously described [35]. Beads were suspended in assay buffer at
2.67610
8/ml and sonicated for 20 seconds immediately prior to
S. aureus Phagocytosis
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final concentration of 2610
8/ml with inhibitors or controls for
binding and internalization, washed three times with HBSS/0.3%
BSA, and incubated an additional 20 minutes in assay buffer with
inhibitors or controls for further internalization. Microplates were
transferred to ice to halt internalization and cells were incubated
on ice for 30 minutes with 20 mg/ml streptavidin-Texas Red (Life
Technologies) in assay buffer to label external beads. Cells were
then washed with HBSS/0.3% BSA and fixed with 4%
paraformaldehyde in PBS for 10 minutes. Cells were stored in
1% paraformaldehyde at 4uC overnight. Cells were incubated for
60 minutes at room temperature with 2 mg/ml Hoechst 33342
(Life Technologies) in PBS for nuclear staining and then stored in
PBS at 4uC until imaged.
For assays of uptake of green fluorescent S. aureus, cells were
incubated for 20 minutes with unopsonized GFP+ RN6390 (final
concentrations of 2610
8/ml), 3610
7/ml for IgG-opsonized GFP+
RN6390, or 1610
7/ml for AlexaFluor 488-conjugated killed
Wood strain) with inhibitors or controls (table 1) for binding and
internalization, washed three times with HBSS/0.3% BSA, and
incubated an additional 20 minutes in assay buffer with inhibitors
or controls for further internalization. Cells were fixed with 4%
paraformaldehyde in PBS for 10 minutes. To achieve red
fluorescent labeling of external bacteria cells were incubated for
15 minutes with PBS/4% FBS (blocking buffer), incubated for 40
minutes with 10 mg/ml mouse monoclonal IgG3 anti-S. aureus
antibody in blocking buffer, washed three times with blocking
buffer, incubated for 20 minutes with 40 mg/ml Texas-RedX-
conjugated goat anti-mouse IgG (Life Technologies) in blocking
buffer, and washed twice with blocking buffer. Hoechst nuclear
staining was then performed as described above.
In some assay validation experiments the phagocytosis assay was
performed using the GFP-expressing RN6390 strain and the single
inhibitor cytochalasin D (to prevent internalization) or vehicle
control, with the exception that prior to fixation and immunola-
beling cells were incubated for an additional 60 minutes at 5%
CO2 and 37uC in assay media with cytochalasin D or control and
with or without 10 mg/ml lysostaphin (Sigma-Aldrich) to dissolve
external S. aureus.
For assays of uptake of non-fluorescent S. aureus strains (Seattle
1945, live Wood or Cowan 1 strain) prelabeling with CellTracker
Blue, incubation of macrophages with bacteria, fixation and
incubation with primary anti-S. aureus antibody was carried out as
described above. For dual red and green fluorescent labeling of
external bacteria, following primary antibody incubation and
three washes with blocking buffer, cells were incubated for 20
minutes with both 40 mg/ml Texas-RedX conjugated goat anti-
mouse IgG (Life Technologies) and 40 mg/ml AlexaFluor 488
conjugated goat anti-mouse IgG Fab fragment (Life Technologies)
in blocking buffer and then washed twice with blocking buffer. For
green fluorescent labeling of internal bacteria cells were permea-
bilized by incubation for 20 minutes with 0.1% saponin in
blocking buffer (BP buffer), then incubated for 60 minutes
with10 mg/ml mouse monoclonal IgG3 anti-S. aureus antibody in
BP buffer, washed three times for five minutes each with BP buffer,
incubated for 30 minutes with 40 mg/ml AlexaFluor 488
conjugated goat anti-mouse IgG Fab fragment in BP buffer, and
washed three times for five minutes each BP buffer. Hoechst
nuclear staining was then performed as described above.
Flow cytometry analysis of particle uptake in suspension
GM-MFs in suspension were prepared as described above.
Polyinosinic acid or chondroitin sulfate were added to a final
concentration of 10 mg/ml and cells were incubated on ice for 30
minutes. Green fluorescent latex beads, commercial killed
AlexaFluor 488-conjugated S. aureus Wood strain and GFP+ S.
aureus RN6390 strain suspensions, were prepared as described
above (but at 26 concentrations). Volumes of 26 particle
suspensions equaling cell suspension volumes were added and
cells were incubated for 30 minutes at room temperature. An
equal volume of 4% paraformaldehyde was added (final
concentration of 2%) and cells were incubated an additional 10
minutes at room temperature for fixation. Cell suspensions were
analyzed using a FacsCanto II flow cytometer (BD Biosciences).
Image acquisition and data analysis
Images were acquired using the BD Pathway 855 High-Content
Bioimager and AttoVision imaging software (BD Biosciences, San
Jose, CA, USA) with a 20X NA075 lens (Olympus, Center Valley,
PA, USA). Green channel images of green fluorescent beads, or of
GFP-expressing or AlexaFluor488-labeled S. aureus were acquired
using 470/40 band-pass (BP) excitation, 515 long-pass (LP)
dichroic and 515 LP emission filters, red channel images of Texas
Red and Texas-RedX labeled beads or S. aureus were imaged using
560/20 BP excitation, 595 LP dichroic and 645 LP emission
filters, and blue channel images of Hoechst nuclear and
CellTracker Blue cytoplasmic labels were acquired using 380/20
BP excitation, 400 LP dichroic, 435 LP emission filters. Auto-
focusing was performed based on Hoechst/CellTracker blue
signals. For each of the three channels confocal images (with flat
field correction and 262 binning) were collected at 1.5 mm
intervals along the Z-axis throughout the thickness of the cells, and
a single combined collapsed confocal stack image was generated.
Three non-overlapping 20X image fields were acquired for each
microplate well to produce a total of nine sets of images (3 fields
63 wells) per condition for each cell donor.
Table 1. Inhibitors used.
Inhibitor Target Control Concentration Vehicle (final %)
poly(I) SR binding chondroitin S. 10, 100 mg/ml PBS (1.0, 10.0)
cytochalasin D actin polymerization vehicle 15 mM DMSO (0.15)
nocodazole microtubule polymerization vehicle 25 mM DMSO (0.5)
Staurosproine ptotein kinases vehicle 1 mM DMSO (0.1)
Go ¨ 6976 protein kinase C vehicle 10 mM DMSO (0.2)
JNK Inhibitor I c-Jun N-terminal kinases inactive analog 4 mM PBS (0.4)
KN-93 CaM Kinase II vehicle 20 mM DMSO (1.0)
doi:10.1371/journal.pone.0006209.t001
S. aureus Phagocytosis
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Using the collapsed confocal stack images, software was
developed to define the cells (blue emission channel image), count
the number of beads per cell (green emission channel image) and
determine if the beads are outside the cell (red emission channel
image) using custom software developed in MATLABH (The
Mathworks, Inc., Natick, MA, USA). Hoechst/CellTracker Blue
images were processed to reduce noise, enhance contrast and
correct for non-uniform field brightness. A gradient-facilitated
watershed segmentation algorithm was used to identify and label
individual cells.
Green and red fluorescent bead and bacteria images were
sharpened and processed to remove background noise. Water-
shed segmentation was used to identify and label individual
bead/bacteria objects. Labeled bead or bacteria objects within
the all particles (green) image channel overlapping (sharing one
or more pixel with) a bead or bacteria object in the external
particle (red) image channel were classified as ‘‘external’’, and
were otherwise classified as ‘‘internal’’. Particle objects sharing
one or more pixel with any cell object were considered to be
associated with that cell.
Typically a total of between 500 and 1000 cells were identified
and quantified (from the nine image fields acquired) per donor per
condition. Binding for each donor and condition was calculated as
the mean number of cell-associated beads or bacteria per cell (total
particles/number of cells). The mean fraction of particles
internalized by all cells for each donor and condition was
calculated from the total numbers of internal and external beads
or bacteria (internal/[internal + external]).
For poly(I)-treated cells mean bound particles/cell and mean
fraction internalization were normalized to chondroitin sulfate
control values, and significant differences were calculated using a
Students paired t-test. For all other inhibitors treatment and
vehicle or inactive analog control values were normalized to those
of a null control, and significant differences were calculated using a
one-way paired ANOVA with Tukey’s multiple comparison of all
Figure 1. Validation of external S. aureus labeling. Adherent GM-MFs were either treated with cytochalasin D (to block uptake) or control prior
to and during incubation with GFP-S. aureus RN6390 and incubated with lysostaphin (to degrade external S. aureus, eliminating external bacteria) or
control following incubation with S. aureus. External S. aureus were labeled with an IgG3 monoclonal mouse anti-S. aureus primary antibody and
Texas-RedX-conjugated goat anti-mouse secondary antibody. (A) No treatment. (B) Treatment with cytochalasin D. (C) Treatment with lysostaphin.
(D) Treatment with both cytochalasin D and lysostaphin. (Original magnification, 200X).
doi:10.1371/journal.pone.0006209.g001
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CA, USA) was used for all graphing and statistical calculations.
Results
Validation of scanning cytometry-based phagocytosis
assay
We adapted a high-throughput phagocytosis assay, previously
developed in our lab for quantification of latex bead phagocytosis
[35], for quantification of S. aureus phagocytosis. Differential
immunolabeling methods were developed for either fluorescent
(GFP-expressing) or non-fluorescent S. aureus to produce an end
result in which all bacteria were green-fluorescent and external
bacteria were also red-fluorescent (see methods for details). To
test that external labeling of bacteria was effective and limited to
external bacteria, GM-MFs were incubated with GFP-S. aureus
RN6390 with or without cytochalasin D treatment (to block
internalization), and incubated after bacterial challenge with or
without lysostaphin – an enzyme produced by Staphylococcus
staphylolyticus that lyses other Staphylococcus species [36] by
hydrolyzing glycylglycine bonds in the polyglycine cross-bridges
between glycopeptide chains in the cell wall peptidoglycan of
Staphylococcus species [37]. Representative composite images of
the four possible combinations are depicted in figure 1. Control
cells (no treatment) show a mixture of internalized (green) and
external (green+red=yellow/orange) S. aureus (figure 1A). Cyto-
chalasin D treatment prevents internalization of bacteria making
them accessible to immunolabeling; most bacteria show antibody
labeling seen as yellow/orange in composite images (figure 1B).
Treatment with lysostaphin alone results in cells with internalized
bacteria (green) only (figure 1C). Treatment with both cytocha-
lasin D (blocking internalization) and lysostaphin (degrading
Figure 2. Scanning cytometry fluorescence imaging with GFP-S. aureus RN6390. Adherent GM-MFs were incubated with unopsonized
GFP-S. aureus RN6390. External S. aureus were labeled with an IgG3 monoclonal mouse anti-S. aureus primary antibody and Texas-RedX-conjugated
goat anti-mouse secondary antibody. Collapsed confocal stack images were acquired by scanning cytometry. (A) CellTracker Blue and Hoechst
channel (cells). (B) GFP channel (all bacteria). (C) Texas Red channel (external bacteria). (D) Composite image. (Original magnification, 200X).
doi:10.1371/journal.pone.0006209.g002
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(figure 1D).
Scanning cytometry was used to acquire confocal image stacks
throughout the depth of the adherent cells and generate single
collapsed confocal stack images for each of the three color
channels (cells, all beads, internal beads) as shown in figure 2.
Custom image analysis software was developed in MATLABH and
used to identify individual cell objects, count internalized vs.
bound but external beads for each cell (figure 3), and calculate
mean total bacteria and percent internalization for all cells in each
well. To validate the automated quantification of bound and
internalized bacteria we compared the results of automated image
analysis to human counting of the same images. Bound and
internalized bacteria per cell were manually counted for 50 cells in
control and cytochalasin D treated conditions and compared to
software quantification of the same 50 cells. Automated counts
varied from manual counts by less than 10% for each measure
(table 2).
The SR inhibitor polyinosinic acid does not block binding
of most unopsonized S. aureus
To examine the role of SRs in phagocytosis of S. aureus,
adherent GM-MFs were treated with the SR blocker poly(I) or the
control polyanion chondroitin sulfate prior to and during
incubation with a panel of S. aureus strains. The assay also tested
uptake of unopsonized latex beads, used as a positive control for
SR-mediated uptake. Binding and internalization was analyzed by
scanning cytometry as described in methods. At 10 mg/ml poly(I)
reduced binding of latex beads by 70% compared with control
(p,.001) and inhibited binding of commercial killed S. aureus
Wood strain by 75% of control (p,.05). In contrast, there was no
significant effect on binding of unopsonized live or heat-killed
Figure 3. Image processing of scanning cytometry images. Image processing and analysis was performed using custom software developed
in MATLABH. (A) Individual cells segmented and identified in cell image. (B) Individual bacteria segmented and identified in all bacteria image. (C)
Individual bacteria segmented and identified in external bacteria image. (D) Internalized (green) and bound but not internalized (red) bacteria
assigned to individual cells (gray).
doi:10.1371/journal.pone.0006209.g003
S. aureus Phagocytosis
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or on that of IgG-opsonized RN6390 (figure 4A). At 100 mg/ml
poly(I), minimal increases in the extent of inhibition of binding of
latex beads or commercial killed Wood strain were observed,
suggesting that maximal effects of this SR inhibitor were already
seen at the lower concentration. At this higher concentration, a
partial inhibition of binding of unopsonized RN6390 was seen
(44%, p,.05). There was no significant effect at this concentration
on binding of live or heat-killed Wood, Cowan 1, and Seattle 1945
(figure 4B). Representative composite images of control and poly(I)
Table 2. Comparison of automated vs. manual quantification of phagocytosis.
source internal bacteria % diff external bacteria % diff total bacteria % diff % internal % diff
manual control 387 - 80 - 467 - 82.9 -
automated control 371 4.1 79 1.3 450 3.6 82.4 0.5
manual +cyto D 10 - 132 - 142 - 7.0 -
automated +cyto D 11 10 122 7.6 133 6.3 8.3 1.3
Numbers in internal, external and total bacteria columns represent total count for fifty cells.
% internal=1006(internal bacteria)/(internal bacteria + external bacteria).
% diff: 1006|automated – manual|/manual.
doi:10.1371/journal.pone.0006209.t002
Figure 4. Effect of poly(I) on binding of S. aureus strains by macrophages: quantitative results. Macrophages were treated with 10 or
100 mg/ml poly(I) or its negative control chondroitin sulfate prior to and during incubation with either fluorescent latex beads or S. aureus. Bars
represent the mean of the fraction of chondroitin sulfate control binding [particles per cell for adherent cells (A,B,D) and mean fluorescence increase
over that of cells without particles for cells in suspension (C)] of three normal donors6SEM. (A) Results of inhibition by 10 mg/ml poly(I) of binding by
adherent GM-MFs. (B) Results of inhibition by 10 vs. 100 mg/ml poly(I) of binding by adherent GM-MFs. (C) Results of inhibition by 10 mg/ml poly(I) of
binding by GM-MFs in suspension. (D) Results of inhibition by 10 vs. 100 mg/ml poly(I) of binding by adherent mouse peritoneal macrophages.
*p,0.05, **p,0.01, ***p,0.001 compared to negative control. CK Wood=commercial killed AlexaFluor 488-conjugated S. aureus, Wood Strain. HK
Wood=heat-killed S. aureus, Wood strain.
doi:10.1371/journal.pone.0006209.g004
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commercial killed Wood strain, and live Wood strain are shown
in figure 5, and are consistent with the automated analysis results.
Since some prior studies used suspension-based assays to
observe SR-mediated uptake of fluorescent S. aureus, we
compared results using adherent vs. suspended macrophages.
GM-MFs in suspension were treated with 10 mg/ml poly(I) or
chondroitin sulfate, and incubated with S. aureus (commercial killed
Wood or RN6390 strain) or green fluorescent latex beads and
analyzed by flow cytometry. Poly(I) reduced binding of latex beads
by 90% compared with control (p,.01) and inhibited binding of
commercial killed S. aureus Wood strain by 85% (p,.01),
consistent with prior findings [2,4,6,8,9,35]. In contrast, there
was no significant effect on binding of S. aureus RN6390 (figure 4C
and figure 6).
We applied a similar analysis to macrophages from a different
species and anatomic site, murine peritoneal exudate macrophag-
es. Adherent mouse thioglycolate-elicited peritoneal macrophages
were pre-treated with 10 or 100 mg/ml poly(I) or chondroitin
sulfate and incubated with S. aureus (commercial killed or live
Wood, Cowan 1 or RN6390 strain). At 10 mg/ml, poly(I) reduced
binding of commercial killed Wood strain by 82% compared with
control (p,.01) and had no effect on binding of other S. aureus
forms (figure 4D). At 100 mg/ml poly(I), binding of commercial
killed Wood strain was inhibited by 80% (p,.01), binding of
RN6390 strain was partially inhibited (similar to our findings with
the human macrophages, ,45%, p,.05) and binding of live
Wood and Cowan 1 strains was unaffected (figure 4D).
Effect of signaling and cytoskeletal inhibitors on
phagocytosis of unopsonized S. aureus strains
To investigate the contribution of cytoskeleton and signaling
pathways in phagocytosis of S. aureus, adherent GM-MFs were
treated with a panel of inhibitors (table 1), or appropriate control
vehicle solutions, prior to and during incubation with a panel of S.
aureus strains as well as unopsonized latex beads, and analyzed by
scanning cytometry as described in methods. The results are
detailed in figures 7 and 8 and summarized in tables 3 and 4 show
uniform effects of cytochalasin D, but extensive heterogeneity in
the effects of other inhibitors among the strains tested.
Inhibition of actin polymerization by cytochalasin D (15 mM)
strongly inhibited internalization of all S. aureus forms and latex
beads (figure 7A). Nocodazole-mediated inhibition of microtubule
formation reduced internalization of latex beads by 45% (p,.001),
Figure 5. Effect of poly(I) on binding of S. aureus strains by adherent GM-MF: image results. Adherent GM-MF were treated with 10 mg/
ml poly(I) or its negative control chondroitin sulfate prior to and during incubation with either fluorescent latex beads or S. aureus (commercial killed
AlexaFluor 488-conjugated Wood or live Wood strain). Images are merged composites of cell (gray), internalized beads or bacteria (green) and
external beads or bacteria (red). (A,B,C) Chondroitin sulfate control. (D,E,F) Poly(I)-treated. (A,D) Cells with fluorescent latex beads. (B,E) Cells with
commercial killed AlexaFluor 488-conjugated Wood strain S. aureus. (C,F) Cells with live Wood strain S. aureus.
doi:10.1371/journal.pone.0006209.g005
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live Wood strain by 29% (p,.001), but had no significant effect on
internalization of other unopsonized S. aureus strains or that of
IgG-opsonized RN6390 strain (figure 7B).
Another example of heterogeneity can be seen in the pattern of
inhibition resulting from staurosporine (1 mM) inhibition of
protein kinase activity. Staurosporine blocked internalization of
unopsonized beads by 59% (p,.001), commercial S. aureus killed
Wood strain by 18% (p,.01) and live Wood strain by 29%
(p,.001), but had no significant effect on internalization of other
unopsonized strains of S. aureus or IgG-opsonized RN6390
(figure 7C).
Additional illustration of varied effects is seen in, inhibition of
CaM kinase II by KN-93 (4 mM) treatment reduced both
internalization (40%, p,.01) and binding (89%, p,.001) of
unopsonized S. aureus RN6390 strain, but had no effect on
phagocytosis of latex beads, other unopsonized S. aureus strains, or
IgG-opsonized RN6390 (figure 7E and figure 8E).
Discussion
We have developed and demonstrated the utility of a high
throughput assays for quantifying phagocytosis of fluorescent or
non-fluorescent bacteria by adherent macrophages in a 96-well
microplate format. Assays of unopsonized latex bead and
opsonized S. aureus RN6390 phagocytosis served as positive
controls. Consistent with previous reports, binding of unopsonized
beads was strongly blocked by the SR antagonist polyinosinic acid,
and uptake of beads was significantly reduced by inhibition of
actin (cytochalasin D) and tubulin (nocodazole) polymerization,
protein kinases (staurosporine), protein kinase C (Go ¨ 6976), and c-
Jun N-terminal kinases (JNK). Also consistent with earlier studies,
our assay showed that the uptake of IgG-opsonized (FccR-
mediated) uptake of S. aureus RN6390 was blocked by inhibition of
cytochalasin D, but not by nocodazole or staurosporine.
Surprisingly, however, the classic SR inhibitor polyinosinic acid
did not block binding of live S. aureus strains or of heat-killed S.
aureus Wood strain, and a marked heterogeneity of inhibition
patterns was found among strains and forms of S. aureus within the
panel of inhibitors investigated.
A number of earlier studies have demonstrated the role of
scavenger receptors, particularly SR-AI/II and MARCO, in
phagocytosis of Gram-positive bacteria via the cell surface ligand
lipoteichoic acid (LTA) [3,5–12]. Many of these studies, including
our own efforts, have utilized a commercial preparation of killed
Wood strain bacteria [2,4,6,8,9]. Our results using this killed
Wood strain in the experiments reported here are quite similar to
prior findings. Binding by GM-MFs or adherent mouse peritoneal
macrophages was almost completely abrogated by polyinosinic
acid at 10 mg/ml. However, at the same concentration, poly-
inosinic acid did not block binding of live or heat-killed Wood
strain, or live Seattle 1945, Cowan 1, or RN6390 strains, and only
partially blocked binding of RN6390 strain at 100 mg/ml. These
results suggest that SRs do not play a major role in the
Figure 6. Effect of poly(I) on binding of S. aureus strains by GM-MF in suspension – flow cytometry. Adherent GM-MF in suspension
were treated with 10 mg/ml poly(I) or its negative control chondroitin sulfate prior to and during incubation with either fluorescent latex beads or S.
aureus (commercial killed Wood or RN6390 strain). Histograms represent green fluorescence intensity counts of 10,000 cells for a single donor. Gray
histograms represent cells without particles. Green histograms represent cells with particles. (A,B,C) Chondroitin sulfate control. (D,E,F) Poly(I) treated.
(A,D) Cells with fluorescent latex beads. (B,E) Cells with commercial killed AlexaFluor 488-conjugated Wood strain S. aureus. (C,F) Cells with
GFP+RN6390 strain S. aureus.
doi:10.1371/journal.pone.0006209.g006
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aureus, and that the commercial killed Wood strain may be peculiar
among S. aureus forms in its SR-mediated uptake. Although the
panel of S. aureus strains studied here is far from comprehensive the
consistency in this regard among those that were studied is
noteworthy. The general concept of SR-mediated uptake of
Gram-positive bacteria via their cell wall LTA, a known SR
ligand, may require refinement. The data suggest that alternative
receptors are likely involved. Indeed, a recent study of AM uptake
of Streptococcus pyogenes revealed an ability of some pathogenic
strains to evade SR-mediated uptake [38].
These findings are distinct from those of Thomas et. al. REF.
They reported that SR-A deficient mice showed diminished
clearance of live S. aureus Cowan 1 strain, as well as decreased
survival, after i.p. injection. They also observed of impaired
unopsonized phagocytosis of Cowan 1 strain in vitro by peritoneal
macrophages from the same mice, and strong in vitro poly(I)
inhibition of unopsonized Cowan 1 strain phagocytosis by
peritoneal macrophages from wild-type mice [5]. One possible
explanation for the discordance between our results and the in vivo
results reported by Thomas et. al. is that mouse peritoneal
macrophages might behave differently than human alveolar-like
Figure 7. Effects of inhibitor panel on internalization of S. aureus strains. Adherent GM-MF were treated with inhibitors or controls (table 1)
prior to and during incubation with either fluorescent latex beads or S. aureus. Bars represent the controls as mean percent internalization of three
normal donors6SEM. (A) Effect of actin polymerization inhibitor cytochalasin D. (B) Effect of microtubule assembly inhibitor nocodazole. (C) Effect of
protein kinase inhibitor staurosporine. (D) Results of protein kinase C inhibitor Go ¨ 6976. (E) Effect of c-Jun N-kinase inhibitor JNK inhibitor I. (F) Effect
of CaM kinase II inhibitor KN-93. *p,0.05, **p,0.01, ***p,0.001 compared to both no treatment control and vehicle or inactive analog control.
doi:10.1371/journal.pone.0006209.g007
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macrophage SR may not play a major role in binding of
unopsonized S. aureus, SR binding may be facilitated after in vivo
opsonization with serum or other components that are SR ligands.
These speculations cannot, however, reconcile our in vitro poly(I)
results with the Cowan 1 strain with those of Thomas et al., since
we were unable to detect inhibition of binding by either human
GM-MFs or wild-type mouse peritoneal macrophages. Hence, the
basis for these differences remains unresolved.
A second surprising finding in our study was a remarkable
variation among S. aureus strains in the effect of signaling inhibitors
on uptake. Whereas inhibition of actin polymerization blocked
uptake of all S. aureus strains and forms and inhibited binding of
RN6390 strain only, blockade of microtubule assembly by
nocodazole impaired internalization of the Wood strain (live or
commercial killed) only and blocked binding of all but the RN6390
strain. Protein kinase inhibition by staurosporine inhibited uptake
of live or commercial killed Wood strain, and PKC inhibition by
Figure 8. Effects of inhibitor panel on binding of S. aureus strains. Adherent GM-MFs were treated with inhibitors or controls (table 1) prior
to and during incubation with either fluorescent latex beads or S. aureus. Bars represent the mean of the fraction of null control particles per cell of
three normal donors6SEM. (A) Results of actin polymerization inhibitor cytochalasin D. (B) Results of microtubule assembly inhibitor nocodazole. (C)
Results of protein kinase inhibitor staurosporine. (D) Results of protein kinase C inhibitor Go ¨ 6976. (E) Results of c-Jun N-kinase inhibitor JNK inhibitor
I. (F) Results of CaM kinase II inhibitor KN-93. *p,0.05, **p,0.01, ***p,0.001 compared to both null control and vehicle or inactive analog control.
doi:10.1371/journal.pone.0006209.g008
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JNK inhibition had no effect on uptake of any strain or form of S.
aureus. Finally CaM Kinase II inhibition by KN-93 blocked both
binding and internalization of unopsonized RN6390 strain, but
had no effect on phagocytosis of other strains. This heterogeneity
of inhibition profiles among strains suggests that multiple signaling
and cytoskeletal/mechanical process schemes for unopsonized
phagocytosis exist and that the scheme used by the macrophage is
determined by some as yet unknown variable strain-dependent
characteristic of S. aureus.
We have used the high-throughput phagocytosis assay to
investigate the effects of a relatively small panel of inhibitors on
phagocytosis of a similarly small number of S. aureus strains.
Further larger-scale studies utilizing more comprehensive inhibitor
panels, or RNAi knockdown cell libraries are possible to more
completely characterize the signaling pathways utilized by these
and other S. aureus strains. The high-throughput scanning-
cytometry based methods developed in the present study are well
suited for these purposes. These techniques could also easily be
adapted to study phagocytosis of other microorganisms by other
cell types, and with the additional labeling of dead vs. live bacteria
could be adapted to allow study of both phagocytosis and killing of
pathogens.
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Table 3. Summary of internalization inhibition results.
Inhibitor Target Beads CK Wood Wood Seattle 1945 RN6390
IgG ops.
RN6390
Poly(I) 10 mg/ml SR binding ------
Poly(I) 100 mg/ml SR binding n d ----n d
Cytochalasin D actin +++ ++ ++++ ++++ ++++ ++++
Nocodazole microtubules ++ + ++ ---
Staurosporine protein kinases +++ + ++ ---
KN-93 CaM Kinase II ----++ -
Go ¨ 6976 protein kinase C ++++ + ----
JNK Inhibitor I c-Jun N-term kin. ++ -----
Beads: biotinlyated carboxylated 1 micron green fluorescent latex beads. CK Wood: commercial killed AlexaFluor 488-conjugated S. aureus Wood strain. Wood: live S.
aureus Wood strain. Seattle 1945: Live S. aureus Seattle 1945 strain. RN 6390: live GFP+S. aureus RN6390 strain. IgG ops. RN6390: IgG a-S. aureus opsonized RN6390.
+ ,25% inhibition. ++25-50% inhibition. +++50-75% inhibition. ++++ .75% inhibition.
- not significantly changed. nd: not determined.
doi:10.1371/journal.pone.0006209.t003
Table 4. Summary of binding inhibition results.
Inhibitor Target Beads CK Wood Wood Seattle 1945 RN6390
IgG ops.
RN6390
Poly(I) 10 mg/ml SR binding +++ ++++ ----
Poly(I) 100 mg/ml SR binding nd ++++ --++ nd
Cytochalasin D actin -- - - +++ ++
Nocodazole microtubules - ++ +++ ++ - ++
Staurosporine protein kinases -- - - ˆˆ -
KN-93 CaM Kinase II -- - - ++++ -
Go ¨ 6976 protein kinase C - -----
JNK Inhibitor I c-Jun N-term kin. ˆˆ ---ˆˆ -
Beads: biotinlyated carboxylated 1 micron green fluorescent latex beads. CK Wood: commercial killed AlexaFluor 488-conjugated S. aureus Wood strain.
Wood: live S. aureus Wood strain. Seattle 1945: Live S. aureus Seattle 1945 strain. RN 6390: live GFP+S. aureus RN6390 strain. IgG ops. RN6390: IgG a-S. aureus opsonized
RN6390.
+ ,25% inhibition. ++25–50% inhibition. +++50–75% inhibition. ++++ .75% inhibition.
- not significantly changed.ˆˆ 25–50% increased. nd: not determined.
doi:10.1371/journal.pone.0006209.t004
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